AMGEN ANNOUNCES WEBCAST OF GOLDMAN SACHS 43RD ANNUAL HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 43rd Annual Healthcare Conference on June 15, 2022, at 1:40 p.m. ET. Key executives, David M. Reese and Peter H. Griffith, will discuss the company's developments. The event will be accessible via a live webcast for media, investors, and the public, and will be archived for 90 days post-event.

Amgen is a leading biotechnology company focused on serious illnesses, with a robust pipeline and a commitment to improving health outcomes.

Positive

• Participation in a major healthcare conference could enhance visibility.
• Webcast availability allows broader access to information for investors.
• Company's focus on high unmet medical needs underscores its strategic direction.

Negative

• None.

THOUSAND OAKS, Calif., June 10, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 43^rd Annual Healthcare Conference at 1:40 p.m. ET on Wednesday, June 15, 2022. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.  In 2021, Amgen was named one of the 25 World's Best Workplaces™ by Fortune and Great Place to Work™ and one of the 100 most sustainable companies in the world by Barron's.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Jessica Akopyan, 805-447-0974 (media) 
Arvind Sood, 805-447-1060 (investors) 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-goldman-sachs-43rd-annual-healthcare-conference-301566045.html

SOURCE Amgen

FAQ

When is Amgen's presentation at the Goldman Sachs Annual Healthcare Conference?

Amgen's presentation is scheduled for June 15, 2022, at 1:40 p.m. ET.

Who will represent Amgen at the conference?

David M. Reese and Peter H. Griffith will represent Amgen at the conference.

How can I access the Amgen conference webcast?

The conference webcast can be accessed on Amgen's website during the event and will be archived for 90 days.

What is Amgen's stock symbol?

Amgen's stock symbol is AMGN.

Where can I find more information about Amgen's business?

More information can be found on Amgen's official website at www.amgen.com.